---
title: "THT 2025: MODERATO II study demonstrates improved echo markers of diastolic dysfunction through AVIM therapy"
date: "2025-02-13T14:07:54.000Z"
publishedDate: "13 février 2025"
summary: "Orchestra BioMed has announced a late-breaking presentation of data on the benefits of atrioventricular interval modulation (AVIM) therapy on patients with diastolic dysfunction at the Technology and Heart Failure Therapeutics (THT) conference (11–13 February, Boston, USA). The retrospective analysis of data from the MODERATO II study demonstrated that AVIM therapy significantly improved echocardiographic markers of [&#8230;] The post THT 2025: MODERATO II study demonstrates improved echo markers of diastolic dysfunction through AVIM therapy appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/tht-2025-moderato-ii-study-demonstrates-improved-echo-markers-of-diastolic-dysfunction-through-avim-therapy/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-02-13-tht-2025-moderato-ii-study-demonstrates-improved-echo-markers-of-diastolic-dysfunction-through-avim-therapy"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2025/02/722FBDC8-15DF-4E25-973C-203809613F479-scaled.jpeg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/tht-2025-moderato-ii-study-demonstrates-improved-echo-markers-of-diastolic-dysfunction-through-avim-therapy/"
---

![THT 2025: MODERATO II study demonstrates improved echo markers of diastolic dysfunction through AVIM therapy](https://cardiovascularnews.com/wp-content/uploads/sites/14/2025/02/722FBDC8-15DF-4E25-973C-203809613F479-scaled.jpeg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/tht-2025-moderato-ii-study-demonstrates-improved-echo-markers-of-diastolic-dysfunction-through-avim-therapy/*

## L’essentiel

Orchestra BioMed has announced a late-breaking presentation of data on the benefits of atrioventricular interval modulation (AVIM) therapy on patients with diastolic dysfunction at the Technology and Heart Failure Therapeutics (THT) conference (11–13 February, Boston, USA). The retrospective analysis of data from the MODERATO II study demonstrated that AVIM therapy significantly improved echocardiographic markers of [&#8230;] The post THT 2025: MODERATO II study demonstrates improved echo markers of diastolic dysfunction through AVIM therapy appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/tht-2025-moderato-ii-study-demonstrates-improved-echo-markers-of-diastolic-dysfunction-through-avim-therapy/
